Heart (journal)
Heart is a peer-reviewed medical journal that focuses on cardiology. It is published by the BMJ Group and covers a wide range of topics related to the heart and cardiovascular system. The journal aims to provide high-quality research, reviews, and educational content for cardiologists, cardiovascular researchers, and other healthcare professionals involved in the management of cardiovascular diseases.
History[edit]
The journal was first established in 1939 under the name British Heart Journal. In 1996, it was renamed Heart to reflect its broader international scope and readership. Over the years, Heart has become one of the leading journals in the field of cardiology.
Scope[edit]
Heart publishes original research articles, review articles, and editorials on various aspects of cardiology, including but not limited to:
- Coronary artery disease
- Heart failure
- Arrhythmias
- Congenital heart disease
- Cardiomyopathies
- Hypertension
- Interventional cardiology
- Cardiovascular imaging
- Preventive cardiology
Abstracting and Indexing[edit]
The journal is abstracted and indexed in several major databases, including:
Editorial Board[edit]
The editorial board of Heart consists of leading experts in the field of cardiology from around the world. The board is responsible for the peer-review process and ensuring the quality and integrity of the published content.
Submission and Peer Review Process[edit]
Authors can submit their manuscripts online through the journal's submission system. All submitted manuscripts undergo a rigorous peer-review process, which includes evaluation by independent experts in the field. The peer-review process ensures that the research published in Heart is of high quality and relevance to the field of cardiology.
Open Access and Licensing[edit]
Heart offers an open access option for authors who wish to make their articles freely available to the public. The journal follows a hybrid open access model, allowing authors to choose between traditional subscription-based publishing and open access publishing.
Related Journals[edit]
See Also[edit]
External Links[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa
Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
